Quantitative susceptibility mapping as a non-invasive imaging biomarker for predicting neurodegeneration in Alzheimer’s disease

Active Research Project
Investigator(s): 
Gloria Chiang, M.D.
Last Updated: 
April 21, 2022

This study will establish cellular sources of quantitative susceptibility mapping (QSM) signal in Alzheimer’s disease (AD) brain tissue, and establish QSM as a predictor of neurodegeneration, using structural and metabolic magnetic resonance (MR) metrics.

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065